The study of Xue et al. also suggested CDK6 as the downstream target of hsa_circ_0081143/miR-646 axis in gastric cancer, which was capable of regulating development and cisplatin-resistance of gastric cancer [39]. This evidence concerns the gene CDK6 and gastric cancer.